$DK

Marcogliese Richard J sold $142K of DK (indirect holdings)

Marcogliese Richard J sold 2,000 indirectly-held shares of Delek US Holdings, Inc. (DK) at $71.05 ($0.14M total) on 2026-08-21.

Original reporting
SEC EDGAR · Marcogliese Richard J
Published Aug 26, 2026, 12:58 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 1:04 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$DK
Neutral
medium confidence
Mentioned
$DK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DKNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to affect DK's valuation materially.

02

Market read

Minor insider sale with limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 4/10Novelty 4/10Timing: filing date 2026-08-25

Background

Form 4 filings disclose insider transactions; traders monitor for signals.

Company-level read

Ticker impact

$DKNeutralMedium confidence
Context

Director Marcogliese Richard J sold 2,000 shares of Delek US Holdings for $142,100 on 2026-08-21, reducing his holdings to 12,880 shares.

Expected impact

Minor downward pressure on DK stock in the short term.

Evidence & confidence

Sale size is small relative to market cap; typical for liquidity needs, unlikely to move price significantly.

Market effects

No material impact on the energy sector.

Limited to US energy equities.

Negligible.

Counterpoint

Insider may be diversifying; sale does not imply negative outlook.

Key entities

  • Delek US Holdings, Inc.

    US energy infrastructure and logistics company.

  • Marcogliese Richard J

    Director of Delek US Holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DKMed

Is DK a Buy Now as Cash Flow Improves Despite Refining Cycle Risks?

Delek US Holdings (DK) reported improved cash flow in Q2, with $262.9M from operations. Management expects $220M annual free-cash-flow improvement. DK trades at a forward P/E of 7.1 and P/S of 0.36. Risks include leverage, crack-spread volatility, and regulatory uncertainty. Zacks ranks DK as a Strong Buy with A-rated Value and Growth scores.

$DKMedAI 8/10

Up another 12% Friday, this AI-picked energy stock is now up +90%

Delek US Holdings (DK) surged 11.6% on Friday, reaching near a 52-week high of $71.47, extending its 90% gain since March. The energy company reported Q2 EPS of $5.48, beating estimates by 148%, with EBITDA up 279% quarter-over-quarter. InvestingPro's AI models identified Delek's potential before its rally, citing strong momentum, earnings turnaround, and cost discipline. The company's performance highlights include record refining margins and operational improvements. InvestingPro members recei

$DKHighAI 8/10

DK Surges As Delek US Earnings Smash Wall Street Targets

Delek US Holdings Inc. (DK) stock surged 11.54% after Q2 earnings beat expectations, with revenue of $4.09B and adjusted EPS up to $5.48. Analysts raised price targets, citing strong refining margins and cash flow. The company's leverage remains high, but cash generation supports dividends and debt reduction. DK's stock is technically in an uptrend, with support at $68 and resistance near $76.

$DKMed

Delek US Q2 Earnings Call Highlights

Delek US (NYSE: DK) Q2 earnings call covered refining margins, throughput guidance, and cash flow. Management said refined-product markets may take several quarters to normalize and that a less backwardated forward curve could lift realized crack spreads. Q3 throughput guided to 296,000-316,000 bpd, with Opex $220-$230M and D&A $110-$120M. Delek Logistics Partners reported ~$144M adjusted EBITDA and reaffirmed 2026 guidance of $520-$560M.

$DKMedAI 8/10

Delek US Holdings (DK) Q2 2026 Earnings Call Transcript

Delek US Holdings (DK) reported Q2 2026 net income of $170 million ($2.71/share) and adjusted net income of $344 million ($5.48/share). Adjusted EBITDA was $639 million, with RVO-adjusted EBITDA of $490 million and RVO-adjusted EPS of $3.64. Logistics segment adjusted EBITDA was a record $144 million. DKL full-year 2026 EBITDA guidance is $520 million to $560 million.

$DKMed

Delek Slides on Q2 Results

Delek US Holdings (NYSE: DK) reported Q2 ended June 30, 2026 net income of $169.5M ($2.71/share) and adjusted net income of $343.9M ($5.48/share). Adjusted EBITDA was $638.7M; excluding RVO impacts, adjusted EPS was $3.64 and adjusted EBITDA $490.1M. Delek Logistics posted adjusted EBITDA of $143.5M and is targeting $520-560M. Delek bought $20M of DK shares and paid $15.6M in dividends, declaring a $0.255 quarterly dividend.